Kopin (KOPN) 10-Q 5 Nov 20 2020 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 26, 2020	Nov. 04, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 26, 2020
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--12-26
Entity File Number	0-19882
Entity Registrant Name	KOPIN CORPORATION
Entity Central Index Key	0000771266
Entity Tax Identification Number	04-2833935
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	125 North Drive
Entity Address, City or Town	Westborough
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01581-3335
City Area Code	(508)
Local Phone Number	870-5959
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	KOPN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		85,053,040

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 26, 2020	Dec. 28, 2019
Current assets:
Cash and equivalents	$ 10,624,506	$ 6,029,247
Marketable debt securities, at fair value	4,988,853	15,752,997
Accounts receivable, net of allowance of $270,000 in 2020 and $938,000 in 2019	6,507,138	6,023,250
Contract assets and unbilled receivables	1,584,171	921,082
Inventory	3,999,107	3,768,696
Prepaid taxes	114,151	104,442
Prepaid expenses and other current assets	2,042,159	1,164,927
Total current assets	29,860,085	33,764,641
Property, plant and equipment, net	1,288,722	1,473,341
Operating lease right-of-use assets	2,018,685	2,753,963
Other assets	161,473	517,411
Equity investments	4,330,060	4,537,159
Total assets	37,659,025	43,046,515
Current liabilities:
Accounts payable	2,805,944	3,998,234
Accrued payroll and expenses	1,880,192	2,203,773
Accrued warranty	508,000	509,000
Contract liabilities and billings in excess of revenues earned	576,419	796,794
Operating lease liabilities	1,064,903	1,041,695
Other accrued liabilities	2,400,234	2,202,217
Customer deposits	2,177,330	33,000
Taxes payable	521,935	525,000
Total current liabilities	11,934,957	11,309,713
Noncurrent contract liabilities and asset retirement obligations	255,050	268,440
Operating lease liabilities, net of current portion	992,712	1,791,590
Other long-term obligations	1,171,091	1,085,160
Stockholders’ equity:
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 89,506,296 shares in 2020 and 88,912,796 shares in 2019; outstanding 82,596,416 in 2020 and 82,536,416 in 2019, respectively	871,096	870,496
Additional paid-in capital	345,094,687	344,456,537
Treasury stock (4,513,256 shares in 2020 and 2019, at cost)	(17,238,669)	(17,238,669)
Accumulated other comprehensive income	1,600,980	1,757,184
Accumulated deficit	(306,911,413)	(301,236,913)
Total Kopin Corporation stockholders’ equity	23,416,681	28,608,635
Noncontrolling interest	(111,466)	(17,023)
Total stockholders’ equity	23,305,215	28,591,612
Total liabilities and stockholders’ equity	$ 37,659,025	$ 43,046,515

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 26, 2020	Dec. 28, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 270,000	$ 938,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	3,000	3,000
Preferred stock, shares issued	0	0
Common Stock, Par or Stated Value Per Share		$ 0.01
Common Stock, Shares Authorized		120,000,000
Common Stock, Shares, Issued	89,506,296	88,912,796
Common Stock, Shares, Outstanding	82,596,416	82,536,416
Treasury stock, shares	4,513,256	4,513,256

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Revenues:
Total revenues	$ 9,512,752	$ 6,139,332	$ 26,206,003	$ 20,792,390
Expenses:
Cost of product revenues	4,825,032	4,689,944	15,252,456	15,809,535
Research and development	2,715,868	2,389,573	7,276,770	10,686,491
Selling, general and administration	3,079,567	5,130,019	9,421,024	16,788,493
Impairment of goodwill		331,344		331,344
Total expenses	10,620,467	12,540,880	31,950,250	43,615,863
Loss from operations	(1,107,715)	(6,401,548)	(5,744,247)	(22,823,473)
Other income (expense):
Interest income	12,751	120,645	120,187	438,316
Other expense, net	(28,600)	(109,614)	(65,680)	(330,821)
Foreign currency transaction gains (losses)	183,795	(88,847)	20,797	(36,320)
Gain on investments				768,000
Total other income and expense	167,946	(77,816)	75,304	839,175
Loss before provision for income taxes and net loss (income) attributable to noncontrolling interest	(939,769)	(6,479,364)	(5,668,943)	(21,984,298)
Tax provision	(29,000)	(26,000)	(100,000)	(78,000)
Net loss	(968,769)	(6,505,364)	(5,768,943)	(22,062,298)
Net loss (income) attributable to the noncontrolling interest	11,329	(120,094)	94,443	(154,478)
Net loss attributable to Kopin Corporation	$ (957,440)	$ (6,625,458)	$ (5,674,500)	$ (22,216,776)
Net loss per share
Basic and diluted	$ (0.01)	$ (0.08)	$ (0.07)	$ (0.28)
Weighted average number of common shares outstanding
Basic and diluted	82,596,416	82,053,698	82,567,401	79,657,677
Net Product Revenues [Member]
Revenues:
Total revenues	$ 6,487,581	$ 4,955,062	$ 19,077,090	$ 14,004,319
Research and Development and Other Revenues [Member]
Revenues:
Total revenues	$ 3,025,171	$ 1,184,270	$ 7,128,913	$ 6,788,071

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Income Statement [Abstract]
Net loss	$ (968,769)	$ (6,505,364)	$ (5,768,943)	$ (22,062,298)
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	(82,815)	(21,163)	69,228	(22,201)
Unrealized holding (loss) gain on marketable securities	(21,725)	39,967	(204,404)	366,224
Reclassification of holding losses in net loss		(8,086)	(21,028)	(15,520)
Other comprehensive (loss) income, net of tax	(104,540)	10,718	(156,204)	328,503
Comprehensive loss	(1,073,309)	(6,494,646)	(5,925,147)	(21,733,795)
Comprehensive loss (income) attributable to the noncontrolling interest	11,329	(120,094)	94,443	(154,478)
Comprehensive loss attributable to Kopin Corporation	$ (1,061,980)	$ (6,614,740)	$ (5,830,704)	$ (21,888,273)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total Kopin Corporation Stockholders Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 29, 2018	$ 785,220	$ 334,491,397	$ (17,238,669)	$ 1,554,587	$ (271,730,661)	$ 47,861,874	$ (149,053)	$ 47,712,821
Balance, shares at Dec. 29, 2018	78,522,066
Stock-based compensation expense		815,842				815,842		815,842
Other comprehensive income				97,317		97,317		97,317
Net (loss) income					(11,330,927)	(11,330,927)	11,017	(11,319,910)
Vesting of restricted stock	$ 100	(100)
Vesting of restricted stock, shares	10,000
Repurchases of restricted stock to satisfy tax withholding obligations	$ (43)	(7,085)				(7,128)		(7,128)
Repurchases of restricted stock to satisfy tax withholding obligations, shares	(4,294)
Sale of registered stock	$ 72,727	7,237,273				7,310,000		7,310,000
Sale of registered stock, shares	7,272,727
Ending balance, value at Mar. 30, 2019	$ 858,004	342,537,327	(17,238,669)	1,651,904	(283,061,588)	44,746,978	(138,036)	44,608,942
Balance, shares at Mar. 30, 2019	85,800,499
Beginning balance, value at Dec. 29, 2018	$ 785,220	334,491,397	(17,238,669)	1,554,587	(271,730,661)	47,861,874	(149,053)	47,712,821
Balance, shares at Dec. 29, 2018	78,522,066
Other comprehensive income								328,503
Net (loss) income								(22,062,298)
Ending balance, value at Sep. 28, 2019	$ 865,669	344,248,350	(17,238,669)	1,883,090	(293,947,437)	35,811,003	5,425	35,816,428
Balance, shares at Sep. 28, 2019	86,566,953
Beginning balance, value at Mar. 30, 2019	$ 858,004	342,537,327	(17,238,669)	1,651,904	(283,061,588)	44,746,978	(138,036)	44,608,942
Balance, shares at Mar. 30, 2019	85,800,499
Stock-based compensation expense		538,474				538,474		538,474
Other comprehensive income				220,468		220,468		220,468
Net (loss) income					(4,260,391)	(4,260,391)	23,367	(4,237,024)
Vesting of restricted stock	$ 600	(600)
Vesting of restricted stock, shares	60,000
Sale of registered stock	$ 7,065	721,466				728,531		728,531
Sale of registered stock, shares	706,454
Ending balance, value at Jun. 29, 2019	$ 865,669	343,796,667	(17,238,669)	1,872,372	(287,321,979)	41,974,060	(114,669)	41,859,391
Balance, shares at Jun. 29, 2019	86,566,953
Stock-based compensation expense		451,683				451,683		451,683
Other comprehensive income				10,718		10,718		10,718
Net (loss) income					(6,625,458)	(6,625,458)	120,094	(6,505,364)
Ending balance, value at Sep. 28, 2019	$ 865,669	344,248,350	(17,238,669)	1,883,090	(293,947,437)	35,811,003	5,425	35,816,428
Balance, shares at Sep. 28, 2019	86,566,953
Beginning balance, value at Dec. 28, 2019	$ 870,496	344,456,537	(17,238,669)	1,757,184	(301,236,913)	28,608,635	(17,023)	28,591,612
Balance, shares at Dec. 28, 2019	87,049,672
Stock-based compensation expense		158,465				158,465		158,465
Other comprehensive income				(98,632)		(98,632)		(98,632)
Net (loss) income					(3,595,519)	(3,595,519)	(61,472)	(3,656,991)
Ending balance, value at Mar. 28, 2020	$ 870,496	344,615,002	(17,238,669)	1,658,552	(304,832,432)	25,072,949	(78,495)	24,994,454
Balance, shares at Mar. 28, 2020	87,049,672
Beginning balance, value at Dec. 28, 2019	$ 870,496	344,456,537	(17,238,669)	1,757,184	(301,236,913)	28,608,635	(17,023)	28,591,612
Balance, shares at Dec. 28, 2019	87,049,672
Other comprehensive income								(156,204)
Net (loss) income								(5,768,943)
Ending balance, value at Sep. 26, 2020	$ 871,096	345,094,687	(17,238,669)	1,600,980	(306,911,413)	23,416,681	(111,466)	23,305,215
Balance, shares at Sep. 26, 2020	87,109,672
Beginning balance, value at Mar. 28, 2020	$ 870,496	344,615,002	(17,238,669)	1,658,552	(304,832,432)	25,072,949	(78,495)	24,994,454
Balance, shares at Mar. 28, 2020	87,049,672
Stock-based compensation expense		161,677				161,677		161,677
Other comprehensive income				46,968		46,968		46,968
Net (loss) income					(1,121,541)	(1,121,541)	(21,642)	(1,143,183)
Vesting of restricted stock	$ 600	(600)
Vesting of restricted stock, shares	60,000
Ending balance, value at Jun. 27, 2020	$ 871,096	344,776,079	(17,238,669)	1,705,520	(305,953,973)	24,160,053	(100,137)	24,059,916
Balance, shares at Jun. 27, 2020	87,109,672
Stock-based compensation expense		318,608				318,608		318,608
Other comprehensive income				(104,540)		(104,540)		(104,540)
Net (loss) income					(957,440)	(957,440)	(11,329)	(968,769)
Ending balance, value at Sep. 26, 2020	$ 871,096	$ 345,094,687	$ (17,238,669)	$ 1,600,980	$ (306,911,413)	$ 23,416,681	$ (111,466)	$ 23,305,215
Balance, shares at Sep. 26, 2020	87,109,672

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Cash flows from operating activities:
Net loss	$ (5,768,943)	$ (22,062,298)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	474,437	597,091
Accretion of premium or discount on marketable debt securities	6,183
Recovery of impairment on marketable debt securities	(150,644)
Stock-based compensation	638,750	1,805,999
Foreign currency (gains) losses	(9,334)	32,483
Change in allowance for bad debt	(667,983)	(56,997)
Unrealized gain on investments		(768,000)
Deferred income taxes	87,402	78,777
Loss on disposal of plant and equipment		487,284
Impairment of goodwill		331,344
Write-off of inventory	1,034,515	2,682,397
Other non-cash items	(1,067)	94,444
Changes in assets and liabilities:
Accounts receivable	185,118	(1,786,687)
Contract assets	(663,089)	2,043,724
Inventory	(1,277,017)	(1,338,233)
Prepaid expenses and other current assets	(735,565)	436,575
Accounts payable and accrued expenses	795,675	(427,603)
Billings in excess of revenue earned	(224,582)	1,034,608
Net cash used in operating activities	(6,276,144)	(16,815,092)
Cash flows from investing activities:
Other assets	374,886	(106,524)
Capital expenditures	(294,595)	(113,009)
Proceeds from sale of marketable debt securities	10,798,117	5,954,139
Cash paid for equity investment		(2,500,000)
Net cash provided by investing activities	10,878,408	3,234,606
Cash flows from financing activities:
Paycheck protection program loan receipt	2,238,000
Paycheck protection program loan repayment	(2,238,000)
Sale of registered stock		8,038,531
Settlements of restricted stock for tax withholding obligations		(7,128)
Net cash provided by financing activities		8,031,403
Effect of exchange rate changes on cash	(7,005)	(19,565)
Net increase (decrease) in cash and cash equivalents	4,595,259	(5,568,648)
Cash and cash equivalents:
Beginning of period	6,029,247	14,326,347
End of period	$ 10,624,506	$ 8,757,699

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Sep. 26, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The condensed consolidated financial statements of Kopin Corporation as of September 26, 2020 and for the three and nine month periods ended September 26, 2020 and September 28, 2019 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2019. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. The December 28, 2019 consolidated balance sheet data was derived from audited financial statements, but certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with Generally Accepted Accounting Principles (GAAP) have been condensed or omitted. The Company reclassified certain prior period amounts to conform to the current period presentation. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred net losses of $ 29.4 million and net cash outflows from operations of $ 21.0 million for the fiscal year ended 2019. The Company incurred a net loss of $ 5.8 million and net cash outflows from operations of $ 6.3 million for the nine months ended September 26, 2020. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable debt securities over the last several years, which was primarily a result of funding operating losses, of which a significant component related to the Company’s ongoing investments in research and development. The Company had $ 15.6 million of cash and cash equivalents and marketable debt securities at September 26, 2020. The Company’s historical and current use of cash in operations combined with limited liquidity resources raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s products are targeted towards the defense and industrial/enterprise wearable markets. Management believes the industrial wearable market is still developing and cannot predict how long it will take to develop or if the Company’s products will be accepted. In addition, the Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future. The COVID-19 pandemic has negatively impacted the global and national economy, disrupted global supply chains, and created significant volatility in and disruption of financial markets. The extent of the impact of the COVID-19 pandemic on the Company’s operational and financial performance, including the ability to execute business strategies and initiatives in the expected time frame to date has been limited. The future impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on future developments, including the duration and spread of the pandemic and related restrictions on travel and transportation, all of which are uncertain and cannot be predicted at this time. An extended period of global supply chain and economic disruption could materially affect the Company’s business, results of operations, financial condition, and access to sources of liquidity. In this regard, the CARES Act established a Paycheck Protection Program (PPP), whereby certain small businesses are eligible for a loan to fund payroll expenses, rent, and related costs. During the second quarter ended June 27, 2020 the Company received loans under the PPP but subsequently voluntarily terminated and repaid the PPP Loans of $ 2.2 million. The Company’s decision to terminate the loans was based on additional guidance issued by the Small Business Administration. There were no prepayment penalties in connection with the voluntary terminations.

ACCOUNTING STANDARDS

ACCOUNTING STANDARDS	9 Months Ended
	Sep. 26, 2020
Accounting Policies [Abstract]
ACCOUNTING STANDARDS	2. ACCOUNTING STANDARDS Accounting Standards Issued But Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments

CASH AND CASH EQUIVALENTS AND M

CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES	9 Months Ended
	Sep. 26, 2020
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES	3. CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents. Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value.” The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations. The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three and nine months ended September 26, 2020 and September 28, 2019. Investments in available-for-sale marketable debt securities were as follows at September 26, 2020 and December 28, 2019: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Gains Unrealized Losses Fair Value 2020 2019 2020 2019 2020 2019 2020 2019 U.S. government and agency backed securities $ 1,004,880 $ 8,304,229 $ 23,990 $ $ $ (7,359 ) $ 1,028,870 $ 8,296,870 Corporate Debt 3,954,345 7,459,298 5,638 - - (3,171 ) 3,959,983 7,456,127 Total $ 4,959,225 $ 15,763,527 $ 29,628 $ - $ - $ (10,530 ) $ 4,988,853 $ 15,752,997 The contractual maturity of the Company’s marketable debt securities was as follows at September 26, 2020 SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five Years Total U.S. government and agency backed securities $ - $ 1,028,870 $ 1,028,870 Corporate debt 1,550,508 2,409,475 3,959,983 Total $ 1,550,508 $ 3,438,345 $ 4,988,853

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 26, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	4. FAIR VALUE MEASUREMENTS Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets. The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS Fair Value Measurement September 26, 2020 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 10,624,506 $ 10,624,506 $ - $ - U.S. Government Securities 1,028,870 - 1,028,870 - Corporate Debt 3,959,983 - 3,959,983 - Equity Investments 4,330,060 271,764 - 4,058,296 $ 19,943,419 $ 10,896,270 $ 4,988,853 $ 4,058,296 Fair Value Measurement at December 28, 2019 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 6,029,247 $ 6,029,247 $ - $ - U.S. Government Securities 8,296,870 - 8,296,870 - Corporate Debt 7,456,127 - 7,456,127 - Equity Investments 4,537,159 386,711 - 4,150,448 $ 26,319,403 $ 6,415,958 $ 15,752,997 $ 4,150,448 Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION December 28, 2019 Net unrealized gains Impairment Charge September 26, 2020 Equity Investments $ 4,150,448 $ 87,848 $ (180,000 ) $ 4,058,296 The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy. Marketable Debt Securities The corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate (“three-month Libor”). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets. Equity Investments The Company acquired an equity interest in a company in the first quarter of 2018 through a $ 1.0 million capital contribution and the contribution of certain intellectual property. During the three and nine months ended September 26, 2020, the Company recorded less than $ 0.1 million of unrealized gains on this equity investment due to a fluctuation in the foreign exchange rate. As of September 26, 2020, the Company owned an 11% interest in this company and the estimated fair value of this equity investment was $ 3.6 million at September 26, 2020. In 2017 the Company had a warrant to acquire up to 15% 2.0 0.1 2.5 0.8 5.2 On September 30, 2019 the Company entered into an Asset Purchase Agreement (the “Solos Purchase Agreement”) pursuant to which the Company sold and licensed certain assets of our Solos TM TM 20% 0.2

INVENTORY

INVENTORY	9 Months Ended
	Sep. 26, 2020
Inventory Disclosure [Abstract]
INVENTORY	5. INVENTORY Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 26, 2020 and December 28, 2019: SCHEDULE OF INVENTORY September 26, 2020 December 28, 2019 Raw materials $ 2,974,810 $ 2,630,156 Work-in-process 591,542 711,475 Finished goods 432,755 427,065 Total $ 3,999,107 $ 3,768,696

NET LOSS PER SHARE

NET LOSS PER SHARE	9 Months Ended
	Sep. 26, 2020
Net loss per share
NET LOSS PER SHARE	6. NET LOSS PER SHARE Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of unvested restricted stock. The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED Three Months Ended Nine Months Ended September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 Non-vested restricted common stock 2,396,624 2,017,624 2,396,624 2,017,624

STOCKHOLDERS_ EQUITY AND STOCK-

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 26, 2020
Equity [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	7. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Restricted Stock Awards In May of 2020, the Company adopted a 2020 Equity Incentive Plan (“2020 Equity Plan”) which authorizes the issuance of shares of common stock to employees, non-employees, and the Board. The 2020 Equity Plan was a successor to the Company’s 2010 Equity Incentive Plan (“2010 Equity Plan”). The number of shares authorized to be issued under the 2020 Equity Plan is four million shares plus shares of the common stock underlying any outstanding award granted under the 2010 Equity Plan that expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares. Registered sale of equity securities On March 15, 2019 and April 10, 2019, the Company sold 7.3 million shares and 0.7 million shares, respectively, of registered common stock for aggregate gross proceeds of $ 8.8 million ($ 1.10 per share), before deducting underwriting discounts and offering expenses paid by the Company of $ 0.7 million. The March 15, 2019 and April 10, 2019 transactions represent approximately 8.9% and 0.8% , respectively, of the Company’s total outstanding shares of common stock as of the date of sale. The net proceeds from the offering were used for general corporate purposes, including working capital. Non-Vested Restricted Common Stock The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested restricted common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting either performance criteria or the Company’s stock achieving a certain price. For non-vested restricted common stock awards that solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards that require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed. Restricted stock activity was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Weighted Average Shares Grant Fair Value Balance, December 28, 2019 1,863,124 $ 1.60 Granted 628,000 0.54 Forfeited (34,500) 2.32 Vested (60,000) 1.12 Balance, September 26, 2020 2,396,624 $ 1.32 On December 31, 2017, the Company amended the employment agreement with our CEO, Dr. John Fan, to expire on December 31, 2020 and as part of the amendment issued restricted stock grants. Of the restricted stock grants issued to Dr. Fan, 640,000 shares will vest upon the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price equal to or greater than $5.25, 150,000 shares will vest at the end of the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $6.00, and 150,000 shares will vest at the end of the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $7.00. All of the grants are subject to certain acceleration events and expire on December 31, 2020 . The total fair value of these awards on December 31, 2017 was $ 1.7 million. The value of restricted stock grants that vest based on market conditions is computed on the date of grant using the Monte Carlo model with the following assumptions: SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS For the three months ended September 26, 2020 Performance price target $ 5.25 $ 6.00 $ 7.00 Expected volatility 48.3% 48.3% 48.3% Interest rate 1.97% 1.97% 1.97% Expected Life (years) 3 3 3 Dividend yield —% —% —% Stock-Based Compensation The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 26, 2020 and September 28, 2019 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Nine Months Ended September 26, 2020 September 28, September 26, 2020 September 28, Cost of product revenues $ 40,620 $ 18,309 $ 70,866 $ 82,524 Research and development 81,133 73,939 193,788 262,454 Selling, general and administrative 196,855 359,435 374,096 1,461,021 Total $ 318,608 $ 451,683 $ 638,750 $ 1,805,999 Unrecognized compensation expense for non-vested restricted common stock as of September 26, 2020 totaled $ 0.6 million and is expected to be recognized over a weighted average period of approximately two years.

ACCRUED WARRANTY

ACCRUED WARRANTY	9 Months Ended
	Sep. 26, 2020
Guarantees and Product Warranties [Abstract]
ACCRUED WARRANTY	8. ACCRUED WARRANTY The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty SCHEDULE OF ACCRUED WARRANTY Balance, December 28, 2019 $ 509,000 Additions 450,000 Claims (451,000) Balance, September 26, 2020 $ 508,000 Extended Warranties Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months standard 12 to 18 month warranty 0.1

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 26, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	9. INCOME TAXES The Company recorded a provision for income taxes of less than $ 0.1 million and $ 0.1 million in the three and nine months ended September 26, 2020, respectively. The Company recorded a provision for income taxes of less than $ 0.1 160.3 million expiring 2022 through 2037 and $ 59.9 million that have an unlimited carryover period. The Company had recognized a full valuation allowance on its domestic and certain foreign net deferred tax assets due to the uncertainty of realization of such assets. The Company recognizes both accrued interest and penalties related to its uncertain tax positions related to intercompany loan interest and potential transfer pricing exposure related to its foreign subsidiaries.

CONTRACT ASSETS AND LIABILITIES

CONTRACT ASSETS AND LIABILITIES	9 Months Ended
	Sep. 26, 2020
Contract Assets And Liabilities
CONTRACT ASSETS AND LIABILITIES	10. CONTRACT ASSETS AND LIABILITIES Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized from customer arrangements, including licensing, exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under other assets in its condensed consolidated balance sheets. Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue. Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY September 26, 2020 December 28, 2019 $ Change % Change Contract assets —current $ 1,584,171 $ 921,082 $ 663,089 72% Contract liabilities—current (576,419 ) (796,794) 220,375 (28)% Contract liabilities—noncurrent (2,350 ) (6,557) 4,207 (64)% Net contract assets $ 1,005,402 $ 117,731 $ 887,671 754 The $ 0.9 million increase in the Company’s net contract assets at September 26, 2020 as compared to December 28, 2019 was primarily due to an increase in inventory and other costs associated with government contracts which recognize revenue over time, and a decrease in billing in excess of revenue earned. In the three and nine months ended September 26, 2020, the Company recognized revenue of less than $ 0.1 0.6 0.1 million and $ 0.3 million, respectively, related to our contract liabilities at December 29, 2018. The Company did not recognize impairment losses on our contract assets in the three and nine months ended September 26, 2020 or September 28, 2019. Performance Obligations The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS Three Months Ended Nine Months Ended September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 Point in time 34 % 55 % 36 % 72 % Over time 66 % 45 % 64 % 28 % Remaining performance obligations represent the transaction price of orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity (“IDIQ”)). As of September 26, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $ 25.8 million which the Company expects to recognize over the next 15 months. The remaining performance obligations represent amounts to be earned under government contracts, which are subject to cancellation.

LEASES

LEASES	9 Months Ended
	Sep. 26, 2020
Leases [Abstract]
LEASES	11. LEASES The Company enters into operating leases primarily for: real estate, including for manufacturing, engineering, research, administration and sales facilities, and information technology (“IT”) equipment. At September 26, 2020 and December 28, 2019, the Company did not have any finance leases. Approximately all of our future lease commitments, and related lease liability, relate to the Company’s real estate leases. Some of the Company’s leases include options to extend or terminate the lease. The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three Months Ended Nine Months Ended September 26, September 28, September 26, 2020 September 28, 2019 Operating lease cost $ 284,529 $ 293,251 $ 851,846 $ 884,499 At September 26, 2020, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2020 (excluding the nine months ended September 26, 2020) $ 299,338 2021 1,053,209 2022 654,617 2023 201,333 Thereafter — Total future lease payments 2,208,497 Less imputed interest (150,882 ) Total $ 2,057,615 The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheets at September 26, 2020 was as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS September 26, 2020 Operating lease liabilities - current $ 1,064,903 Operating lease liabilities -noncurrent 992,712 Total lease liabilities $ 2,057,615 Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Nine months ended September 26, 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 892,221 Other information related to leases was as follows: September 26, 2020 Weighted Average Discount Rate - Operating Leases 6.16 % Weighted Average Remaining Lease Term - Operating Leases (in years) 2.14

SEGMENTS AND DISAGGREGATION OF

SEGMENTS AND DISAGGREGATION OF REVENUE	9 Months Ended
	Sep. 26, 2020
Segment Reporting [Abstract]
SEGMENTS AND DISAGGREGATION OF REVENUE	12. SEGMENTS AND DISAGGREGATION OF REVENUE We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine if any changes have occurred that would affect our reportable segments. In the fourth quarter of 2019, as a result of the changes in our operations and management structure we commenced reporting under one segment. We have retrospectively adjusted our segment disclosures to present one reportable segment, as our Chief Executive Officer, who is our chief operating decision maker (“CODM”), reviews results on a total company basis. Total long-lived assets by country at September 26, 2020 and December 28, 2019 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) September 26, 2020 December 28, 2019 U.S. $ 2,936 $ 3,647 United Kingdom 299 442 China 17 37 Japan 55 101 Total $ 3,307 $ 4,227 We disaggregate our revenue from contracts with customers by geographic location and by display application, as we believe it best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. During the three and nine months ended September 26, 2020 and September 28, 2019, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three Months Ended Nine Months Ended September 26, September 28, September 26, September 28, (In thousands) Defense $ 4,769 $ 1,968 $ 12,772 $ 5,207 Industrial 1,650 2,625 5,229 7,262 Consumer 68 360 521 1,510 Other - 2 553 25 R&D 2,563 1,184 6,295 2,452 License & Royalties 463 - 836 4,336 Total Revenues $ 9,513 $ 6,139 $ 26,206 $ 20,792 During the three and nine months ended September 26, 2020 and September 28, 2019, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE Three Months Ending Nine Months Ending September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 (In thousands) United States $ 7,828 $ 3,453 $ 21,530 $ 8,464 Other Americas - 10 100 35 Total Americas 7,828 3,463 21,630 8,499 Asia - Pacific 1,475 2,307 3,783 9,997 Europe 210 350 793 2,268 Other - 19 - 28 Total Revenues $ 9,513 $ 6,139 $ 26,206 $ 20,792

LITIGATION

LITIGATION	9 Months Ended
	Sep. 26, 2020
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	13. LITIGATION The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations and proceedings are inherently uncertain and it is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period. BlueRadios, Inc. v. Kopin Corporation, Civil Action No. 16-02052-JLK (D. Col.): On August 12, 2016, BlueRadios, Inc. (“BlueRadios”) filed a complaint in the U.S. District Court for the District of Colorado, alleging that the Company breached a contract between it and BlueRadios concerning an alleged joint venture between the Company and BlueRadios to design, develop and commercialize micro-display products with embedded wireless technology referred to as “Golden-i” breached the covenant of good faith and fair dealing associated with that contract, breached its fiduciary duty to BlueRadios, and misappropriated trade secrets owned by BlueRadios in violation of Colorado law (C.R.S. § 7-74-104(4)) and the Defend Trade Secrets Act (18 U.S.C. § 1836(b)(1)). BlueRadios further alleges that the Company was unjustly enriched by its alleged misconduct, BlueRadios is entitled to an accounting to determine the amount of profits obtained by the Company as a result of its alleged misconduct, and the inventorship on at least ten patents or patent applications owned by the Company need to be corrected to list BlueRadios’ employees as inventors and thereby list BlueRadios as co-assignees of the patents. BlueRadios seeks monetary, declaratory, and injunctive relief, including for alleged non-payment of engineering retainer fees. On October 11, 2016, the Company filed its Answer and Affirmative Defenses. The parties completed expert depositions on November 15, 2019. On December 2, 2019, the Company filed a Motion for Partial Summary Judgment requesting the Court dismiss counts 2-7 in their entirety and counts 1 and 8 in part. BlueRadios also filed a Motion for Partial Summary Judgment alleging it is the co-owner of U.S. Patent No. 8,909,296. Responses to the Motions for Partial Summary Judgment were filed on January 15, 2020, and replies were filed on February 19, 2020. On September 25, 2020, the Court denied BlueRadios’ Motion for Partial Summary Judgment. The Court has not yet ruled on the Company’s motion for Partial Summary Judgment. A trial date has not yet been set by the Court. The Company has not concluded a loss from this matter is probable; therefore, we have not recorded an accrual for litigation or claims related to this matter for the period ended September 26, 2020. The Company will continue to evaluate information as it becomes known and will record an estimate for losses at the time or times when it is both probable that a loss has been incurred and the amount of the loss is reasonably estimable.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 26, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	14. RELATED PARTY TRANSACTIONS The Company may from time to time enter into agreements with stockholders, affiliates and other companies engaged in certain aspects of the display, electronics, optical and software industries as part of our business strategy. In addition, the wearable computing product market is relatively new and there may be other technologies the Company needs to purchase from affiliates to enhance its product offering. During the three and nine months ended September 26, 2020 and September 28, 2019, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three Months Ended September 26, 2020 September 28, 2019 Revenues Purchases Sales Purchases Solos Inc. $ 868 $ — $ — $ — RealWear, Inc. 894,976 10,545 538,930 — $ 895,843 $ 10,545 $ 538,930 $ — Nine Months Ended September 26, 2020 September 28, 2019 Revenues Purchases Sales Purchases Goertek $ — $ — $ — $ 747,154 Solos Inc. 247,326 — — — RealWear, Inc. 1,266,878 10,545 5,731,574 — $ 1,514,204 $ 10,545 $ 5,731,574 $ 747,154 At September 26, 2020 and December 28, 2019, the Company had the following receivables, contract liabilities and payables with related parties: September 26, 2020 December 28, 2019 Receivables Contract Liabilities Payables Receivables Contract Assets Payables Solos Inc. $ 868 $ — $ 8,750 $ 283,203 $ — $ 8,750 RealWear, Inc. 694,783 327,610 10,545 646,848 — — $ 695,651 $ 327,610 $ 19,295 $ 930,051 $ — $ 8,750

CASH AND CASH EQUIVALENTS AND_2

CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES (Tables)	9 Months Ended
	Sep. 26, 2020
Cash and Cash Equivalents [Abstract]
SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES	Investments in available-for-sale marketable debt securities were as follows at September 26, 2020 and December 28, 2019: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Gains Unrealized Losses Fair Value 2020 2019 2020 2019 2020 2019 2020 2019 U.S. government and agency backed securities $ 1,004,880 $ 8,304,229 $ 23,990 $ $ $ (7,359 ) $ 1,028,870 $ 8,296,870 Corporate Debt 3,954,345 7,459,298 5,638 - - (3,171 ) 3,959,983 7,456,127 Total $ 4,959,225 $ 15,763,527 $ 29,628 $ - $ - $ (10,530 ) $ 4,988,853 $ 15,752,997
SCHEDULE OF MARKETABLE DEBT SECURITIES	The contractual maturity of the Company’s marketable debt securities was as follows at September 26, 2020 SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five Years Total U.S. government and agency backed securities $ - $ 1,028,870 $ 1,028,870 Corporate debt 1,550,508 2,409,475 3,959,983 Total $ 1,550,508 $ 3,438,345 $ 4,988,853

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 26, 2020
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS	The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS Fair Value Measurement September 26, 2020 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 10,624,506 $ 10,624,506 $ - $ - U.S. Government Securities 1,028,870 - 1,028,870 - Corporate Debt 3,959,983 - 3,959,983 - Equity Investments 4,330,060 271,764 - 4,058,296 $ 19,943,419 $ 10,896,270 $ 4,988,853 $ 4,058,296 Fair Value Measurement at December 28, 2019 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 6,029,247 $ 6,029,247 $ - $ - U.S. Government Securities 8,296,870 - 8,296,870 - Corporate Debt 7,456,127 - 7,456,127 - Equity Investments 4,537,159 386,711 - 4,150,448 $ 26,319,403 $ 6,415,958 $ 15,752,997 $ 4,150,448
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION	Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION December 28, 2019 Net unrealized gains Impairment Charge September 26, 2020 Equity Investments $ 4,150,448 $ 87,848 $ (180,000 ) $ 4,058,296

INVENTORY (Tables)

INVENTORY (Tables)	9 Months Ended
	Sep. 26, 2020
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORY	Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 26, 2020 and December 28, 2019: SCHEDULE OF INVENTORY September 26, 2020 December 28, 2019 Raw materials $ 2,974,810 $ 2,630,156 Work-in-process 591,542 711,475 Finished goods 432,755 427,065 Total $ 3,999,107 $ 3,768,696

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	9 Months Ended
	Sep. 26, 2020
Net loss per share
SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED	The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED Three Months Ended Nine Months Ended September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 Non-vested restricted common stock 2,396,624 2,017,624 2,396,624 2,017,624

STOCKHOLDERS_ EQUITY AND STOC_2

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 26, 2020
Equity [Abstract]
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY	Restricted stock activity was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Weighted Average Shares Grant Fair Value Balance, December 28, 2019 1,863,124 $ 1.60 Granted 628,000 0.54 Forfeited (34,500) 2.32 Vested (60,000) 1.12 Balance, September 26, 2020 2,396,624 $ 1.32
SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS	SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS For the three months ended September 26, 2020 Performance price target $ 5.25 $ 6.00 $ 7.00 Expected volatility 48.3% 48.3% 48.3% Interest rate 1.97% 1.97% 1.97% Expected Life (years) 3 3 3 Dividend yield —% —% —%
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 26, 2020 and September 28, 2019 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Nine Months Ended September 26, 2020 September 28, September 26, 2020 September 28, Cost of product revenues $ 40,620 $ 18,309 $ 70,866 $ 82,524 Research and development 81,133 73,939 193,788 262,454 Selling, general and administrative 196,855 359,435 374,096 1,461,021 Total $ 318,608 $ 451,683 $ 638,750 $ 1,805,999

ACCRUED WARRANTY (Tables)

ACCRUED WARRANTY (Tables)	9 Months Ended
	Sep. 26, 2020
Guarantees and Product Warranties [Abstract]
SCHEDULE OF ACCRUED WARRANTY	SCHEDULE OF ACCRUED WARRANTY Balance, December 28, 2019 $ 509,000 Additions 450,000 Claims (451,000) Balance, September 26, 2020 $ 508,000

CONTRACT ASSETS AND LIABILITI_2

CONTRACT ASSETS AND LIABILITIES (Tables)	9 Months Ended
	Sep. 26, 2020
Contract Assets And Liabilities
SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY	Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY September 26, 2020 December 28, 2019 $ Change % Change Contract assets —current $ 1,584,171 $ 921,082 $ 663,089 72% Contract liabilities—current (576,419 ) (796,794) 220,375 (28)% Contract liabilities—noncurrent (2,350 ) (6,557) 4,207 (64)% Net contract assets $ 1,005,402 $ 117,731 $ 887,671 754
SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS	The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS Three Months Ended Nine Months Ended September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 Point in time 34 % 55 % 36 % 72 % Over time 66 % 45 % 64 % 28 %

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 26, 2020
Leases [Abstract]
SCHEDULE OF LEASE EXPENSE	The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three Months Ended Nine Months Ended September 26, September 28, September 26, 2020 September 28, 2019 Operating lease cost $ 284,529 $ 293,251 $ 851,846 $ 884,499
SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE	At September 26, 2020, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2020 (excluding the nine months ended September 26, 2020) $ 299,338 2021 1,053,209 2022 654,617 2023 201,333 Thereafter — Total future lease payments 2,208,497 Less imputed interest (150,882 ) Total $ 2,057,615
SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS	The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheets at September 26, 2020 was as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS September 26, 2020 Operating lease liabilities - current $ 1,064,903 Operating lease liabilities -noncurrent 992,712 Total lease liabilities $ 2,057,615
SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES	Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Nine months ended September 26, 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 892,221 Other information related to leases was as follows: September 26, 2020 Weighted Average Discount Rate - Operating Leases 6.16 % Weighted Average Remaining Lease Term - Operating Leases (in years) 2.14

SEGMENTS AND DISAGGREGATION O_2

SEGMENTS AND DISAGGREGATION OF REVENUE (Tables)	9 Months Ended
	Sep. 26, 2020
Segment Reporting [Abstract]
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS	Total long-lived assets by country at September 26, 2020 and December 28, 2019 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) September 26, 2020 December 28, 2019 U.S. $ 2,936 $ 3,647 United Kingdom 299 442 China 17 37 Japan 55 101 Total $ 3,307 $ 4,227
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT	During the three and nine months ended September 26, 2020 and September 28, 2019, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three Months Ended Nine Months Ended September 26, September 28, September 26, September 28, (In thousands) Defense $ 4,769 $ 1,968 $ 12,772 $ 5,207 Industrial 1,650 2,625 5,229 7,262 Consumer 68 360 521 1,510 Other - 2 553 25 R&D 2,563 1,184 6,295 2,452 License & Royalties 463 - 836 4,336 Total Revenues $ 9,513 $ 6,139 $ 26,206 $ 20,792
SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE	During the three and nine months ended September 26, 2020 and September 28, 2019, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE Three Months Ending Nine Months Ending September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 (In thousands) United States $ 7,828 $ 3,453 $ 21,530 $ 8,464 Other Americas - 10 100 35 Total Americas 7,828 3,463 21,630 8,499 Asia - Pacific 1,475 2,307 3,783 9,997 Europe 210 350 793 2,268 Other - 19 - 28 Total Revenues $ 9,513 $ 6,139 $ 26,206 $ 20,792

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Sep. 26, 2020
Related Party Transactions [Abstract]
SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES	During the three and nine months ended September 26, 2020 and September 28, 2019, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three Months Ended September 26, 2020 September 28, 2019 Revenues Purchases Sales Purchases Solos Inc. $ 868 $ — $ — $ — RealWear, Inc. 894,976 10,545 538,930 — $ 895,843 $ 10,545 $ 538,930 $ — Nine Months Ended September 26, 2020 September 28, 2019 Revenues Purchases Sales Purchases Goertek $ — $ — $ — $ 747,154 Solos Inc. 247,326 — — — RealWear, Inc. 1,266,878 10,545 5,731,574 — $ 1,514,204 $ 10,545 $ 5,731,574 $ 747,154 At September 26, 2020 and December 28, 2019, the Company had the following receivables, contract liabilities and payables with related parties: September 26, 2020 December 28, 2019 Receivables Contract Liabilities Payables Receivables Contract Assets Payables Solos Inc. $ 868 $ — $ 8,750 $ 283,203 $ — $ 8,750 RealWear, Inc. 694,783 327,610 10,545 646,848 — — $ 695,651 $ 327,610 $ 19,295 $ 930,051 $ — $ 8,750

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 27, 2020	Sep. 26, 2020	Dec. 28, 2019
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent		$ 5,800,000
Net cash outflows from operations		6,300,000
Cash and cash equivalents and marketable debt securities		$ 15,600,000
Paycheck Protection Program Loan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Early Repayment of Subordinated Debt	$ 2,200,000
Fiscal Period Twenty Ninteen [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent			$ 29,400,000
Net cash outflows from operations			$ 21,000,000

SCHEDULE OF AVAILABLE-FOR-SALE

SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES (Details) - USD ($)	Sep. 26, 2020	Dec. 28, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	$ 4,959,225	$ 15,763,527
Unrealized Gains	29,628
Unrealized Losses		(10,530)
Fair Value	4,988,853	15,752,997
U S Government and Agency Backed Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	1,004,880	8,304,229
Unrealized Gains	23,990
Unrealized Losses		(7,359)
Fair Value	1,028,870	8,296,870
Corporate Debt [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	3,954,345	7,459,298
Unrealized Gains	5,638
Unrealized Losses		(3,171)
Fair Value	$ 3,959,983	$ 7,456,127

SCHEDULE OF MARKETABLE DEBT SEC

SCHEDULE OF MARKETABLE DEBT SECURITIES (Details)	Sep. 26, 2020USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year	$ 1,550,508
One to Five Years	3,438,345
Total	4,988,853
U S Government and Agency Backed Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year
One to Five Years	1,028,870
Total	1,028,870
Corporate Debt [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year	1,550,508
One to Five Years	2,409,475
Total	$ 3,959,983

SCHEDULE OF FAIR VALUE MEASUREM

SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS (Details) - USD ($)	Sep. 26, 2020	Dec. 28, 2019
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	$ 19,943,419	$ 26,319,403
Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	10,896,270	6,415,958
Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	4,988,853	15,752,997
Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	4,058,296	4,150,448
Cash and Cash Equivalents [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	10,624,506	6,029,247
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	10,624,506	6,029,247
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
U.S. Government Securities [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	1,028,870	8,296,870
U.S. Government Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
U.S. Government Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	1,028,870	8,296,870
U.S. Government Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Corporate Debt [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	3,959,983	7,456,127
Corporate Debt [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Corporate Debt [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	3,959,983	7,456,127
Corporate Debt [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Equity Investments [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	4,330,060	4,537,159
Equity Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	271,764	386,711
Equity Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Equity Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	$ 4,058,296	$ 4,150,448

SCHEDULE OF FAIR VALUE, ASSETS

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION (Details) - Equity Investments [Member]	9 Months Ended
	Sep. 26, 2020USD ($)
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instrument fair value, beginnning	$ 4,150,448
Net unrealized losses	87,848
Impairment Charge	(180,000)
Financial instrument fair value, ending	$ 4,058,296

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Dec. 28, 2019	Jun. 29, 2019	Jun. 30, 2018	Mar. 31, 2018	Sep. 26, 2020	Sep. 28, 2019	Dec. 30, 2017	Sep. 30, 2019	May 31, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Payments to Acquire Equity Method Investments				$ 1,000,000		$ 2,500,000
Unrealized Gain (Loss) on Securities		$ 800,000			$ 100,000
Ownership percentage interest					11.00%
Equity Method Investments, Fair Value Disclosure					$ 3,600,000
Impairment of equity security	$ 5,200,000
Solos Inc [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ownership percentage interest								20.00%
Series A Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Gain on fair value of warrant							$ 2,000,000
Loss on warrant			$ 100,000
Series B [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Securities, FV-NI									$ 2,500,000
Maximum [Member] | Solos Inc [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Impairment on investment					$ 200,000
Warrant [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ownership percentage in equity investment warrant							15.00%

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($)	Sep. 26, 2020	Dec. 28, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 2,974,810	$ 2,630,156
Work-in-process	591,542	711,475
Finished goods	432,755	427,065
Total	$ 3,999,107	$ 3,768,696

SCHEDULE OF WEIGHTED-AVERAGE CO

SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Net loss per share
Non-vested restricted common stock	2,396,624	2,017,624	2,396,624	2,017,624

SCHEDULE OF NON-VESTED RESTRICT

SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY (Details)	9 Months Ended
	Sep. 26, 2020$ / sharesshares
Equity [Abstract]
Number of Shares, Restricted stock Outstanding Beginning | shares	1,863,124
Weighted Average Grant Date Fair Value, Restricted stock Outstanding Beginning | $ / shares	$ 1.60
Number of Shares, Restricted stock Granted | shares	628,000
Weighted Average Grant Date Fair Value, Restricted stock Granted | $ / shares	$ 0.54
Number of Shares, Restricted stock Forfeited | shares	(34,500)
Weighted Average Grant Date Fair Value, Restricted stock Forfeited | $ / shares	$ 2.32
Number of Shares, Restricted stock Vested | shares	(60,000)
Weighted Average Grant Date Fair Value, Restricted stock Vested | $ / shares	$ 1.12
Number of Shares, Restricted stock Outstanding Ending | shares	2,396,624
Weighted Average Grant Date Fair Value, Restricted stock Outstanding Ending | $ / shares	$ 1.32

SCHEDULE OF SHARE-BASED PAYMENT

SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS (Details)	3 Months Ended
	Sep. 26, 2020$ / shares
Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 5.25
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield	0.00%
Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 6
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield	0.00%
Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 7
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield	0.00%

SCHEDULE OF STOCK-BASED COMPENS

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Share-based Payment Arrangement, Expense	$ 318,608	$ 451,683	$ 638,750	$ 1,805,999
Cost of Product Revenues [Member]
Share-based Payment Arrangement, Expense	40,620	18,309	70,866	82,524
Research and Development [Member]
Share-based Payment Arrangement, Expense	81,133	73,939	193,788	262,454
Selling, General and Administrative [Member]
Share-based Payment Arrangement, Expense	$ 196,855	$ 359,435	$ 374,096	$ 1,461,021

STOCKHOLDERS_ EQUITY AND STOC_3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($) $ / shares in Units, $ in Millions	Apr. 10, 2019	Mar. 15, 2019	Dec. 31, 2017	Sep. 26, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	700,000	7,300,000
Gross proceeds from registered sale equity securities	$ 8.8
Shares Issued, Price Per Share		$ 1.10
Underwriting discounts and offering expenses from sale of equity	$ 0.7
Percentage of common stock outstanding	0.80%	8.90%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				628,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount				$ 0.6
Unrecognized compensation weighted average period				two years.
Employment Agreement [Member] | Dr. John Fan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
[custom:GrantExpirationDate]			Dec. 31, 2020
Total fair value awards			$ 1.7
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $5.25 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			640,000
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $6.00 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			150,000
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $7.00 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			150,000

SCHEDULE OF ACCRUED WARRANTY (D

SCHEDULE OF ACCRUED WARRANTY (Details)	9 Months Ended
	Sep. 26, 2020USD ($)
Guarantees and Product Warranties [Abstract]
Balance, December 28, 2019	$ 509,000
Additions	450,000
Claims	(451,000)
Balance, September 26, 2020	$ 508,000

ACCRUED WARRANTY (Details Narra

ACCRUED WARRANTY (Details Narrative) $ in Millions	9 Months Ended
	Sep. 26, 2020USD ($)
Revenue Benchmark [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Extended Product Warranty Description	The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months
Standard Product Warranty Description	standard 12 to 18 month warranty
Warranty [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Product warranty term	The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty
Deferred revenue	$ 0.1

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Income Tax Disclosure [Abstract]
Current Income Tax Expense (Benefit)	$ 0.1	$ 0.1	$ 0.1	$ 0.1
Operating Loss Carryforwards	160.3		$ 160.3
Net operating loss expiry period			expiring 2022 through 2037
Operating loss carryforwards unlimited	$ 59.9		$ 59.9

SCHEDULE OF CONTRACT WITH CUSTO

SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY (Details) - USD ($)	Sep. 26, 2020	Dec. 28, 2019
Contract Assets And Liabilities
Contract assets-current	$ 1,584,171	$ 921,082
Change in contract assets-current	$ 663,089
Percentage of change in contract assets-current	72.00%
Contract liabilities-current	$ (576,419)	(796,794)
Change in contract liabilities current	$ 220,375
Percentage of change in contract liabilities	(28.00%)
Contract liabilities-noncurrent	$ (2,350)	(6,557)
Change in contract liabilities-noncurrent	$ 4,207
Percentage of change in contract liabilities-noncurrent	(64.00%)
Net contract assets	$ 1,005,402	$ 117,731
Change in Net contract assets	$ 887,671
Percentage of change in Net contract assets	754.00%

SCHEDULE OF SATISFACTION OF PER

SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS (Details)	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Revenue percentage from products and services transferred customers	34.00%	55.00%	36.00%	72.00%
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Revenue percentage from products and services transferred customers	66.00%	45.00%	64.00%	28.00%

CONTRACT ASSETS AND LIABILITI_3

CONTRACT ASSETS AND LIABILITIES (Details Narrative) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 27, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Increase in contract assets and liabilities			$ 0.9
Contract with Customer, Liability, Revenue Recognized		$ 0.1		$ 0.3
Revenue, Remaining Performance Obligation, Amount			25.8
Maximum [Member]
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Contract with Customer, Liability, Revenue Recognized	$ 0.1		$ 0.6

SCHEDULE OF LEASE EXPENSE (Deta

SCHEDULE OF LEASE EXPENSE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Leases [Abstract]
Operating lease cost	$ 284,529	$ 293,251	$ 851,846	$ 884,499

SCHEDULE OF FUTURE LEASE PAYMEN

SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE (Details)	Sep. 26, 2020USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year	$ 299,338
Lessee, Operating Lease, Liability, to be Paid, Year One	1,053,209
Lessee, Operating Lease, Liability, to be Paid, Year Two	654,617
Lessee, Operating Lease, Liability, to be Paid, Year Three	201,333
Thereafter
Lessee, Operating Lease, Liability, to be Paid	2,208,497
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(150,882)
Operating lease liability	$ 2,057,615

SCHEDULE OF OPERATING LEASE PAY

SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS (Details)	Sep. 26, 2020USD ($)
Leases [Abstract]
Operating lease liabilities - current	$ 1,064,903
Operating lease liabilities -noncurrent	992,712
Total lease liabilities	$ 2,057,615

SCHEDULE OF SUPPLEMENTAL INFORM

SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)	9 Months Ended
	Sep. 26, 2020USD ($)
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 892,221
Weighted Average Discount Rate - Operating Leases	6.16%
Weighted Average Remaining Lease Term Operating Leases (in years)	2.14

SCHEDULE OF LONG-LIVED ASSETS B

SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS (Details) - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	$ 3,307	$ 4,227
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	2,936	3,647
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	299	442
CHINA
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	17	37
JAPAN
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Long-lived Assets	$ 55	$ 101

SCHEDULE OF SEGMENT REPORTING I

SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Revenue from External Customer [Line Items]
Total Revenues	$ 9,513	$ 6,139	$ 26,206	$ 20,792
Defense [Member]
Revenue from External Customer [Line Items]
Total Revenues	4,769	1,968	12,772	5,207
Industrial [Member]
Revenue from External Customer [Line Items]
Total Revenues	1,650	2,625	5,229	7,262
Consumer [Member]
Revenue from External Customer [Line Items]
Total Revenues	68	360	521	1,510
Product and Service, Other [Member]
Revenue from External Customer [Line Items]
Total Revenues		2	553	25
Research and Development [Member]
Revenue from External Customer [Line Items]
Total Revenues	2,563	1,184	6,295	2,452
License And Royalties [Member]
Revenue from External Customer [Line Items]
Total Revenues	$ 463		$ 836	$ 4,336

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 9,513	$ 6,139	$ 26,206	$ 20,792
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	7,828	3,453	21,530	8,464
Other Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues		10	100	35
Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	7,828	3,463	21,630	8,499
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	1,475	2,307	3,783	9,997
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	210	350	793	2,268
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues		$ 19		$ 28

SCHEDULE OF TRANSACTIONS WITH R

SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019	Dec. 28, 2019
Related Party Transaction [Line Items]
Revenues	$ 895,843	$ 538,930	$ 1,514,204	$ 5,731,574
Purchases	10,545		10,545	747,154
Receivables	695,651		695,651		$ 930,051
Contract liabilities	327,610		327,610
Payables	19,295		19,295		8,750
Contract assets
Solos Inc [Member]
Related Party Transaction [Line Items]
Revenues	868		247,326
Purchases
Receivables	868		868		283,203
Contract liabilities
Payables	8,750		8,750		8,750
Contract assets
RealWear, Inc. [Member]
Related Party Transaction [Line Items]
Revenues	894,976	538,930	1,266,878	5,731,574
Purchases	10,545		10,545
Receivables	694,783		694,783		646,848
Contract liabilities	327,610		327,610
Payables	$ 10,545		10,545
Contract assets
Goertek [Member]
Related Party Transaction [Line Items]
Revenues
Purchases				$ 747,154